PATENT CLAIM ANALYSIS

Application Number: 16296766
Application Type: Utility
Filing Date: 2019-03
Publication Date: 2019-07
Patent Classification: ["424", "130100"]

Abstract:
Compounds of formula (I): wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 12 , X, A and n are as defined in the description. Medicinal products containing the same which are useful in treating pathologies involving a deficit in apoptosis, such as cancer, auto-immune diseases, and diseases of the immune system.

Claim (Index 21):
The method according to  claim 1 , wherein the condition is selected from cancer of the bladder, cancer of the uterus, cancer of the colon, cancer of the esophagus, cancer of the liver, ovarian cancer, prostate cancer, and pancreatic cancer.

Metadata:
- Claim Count in Document: 62.0
- Percentile: 99.0
- Lexical Diversity: 1.59574
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14576683', '15492306', '15738601', '16069891', '15737479']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8758486719573542
- 35 USC 102 Novelty (BERT): 0.6388002066327083
- Combined Prediction Score: 0.8521438254248895
- Mean Citation Score: 685.7307800000002
- Max Citation Score: 719.5483
- Similarity Product: 553.1973252719164

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test